Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy

Nature Medicine

Volumn 13, Issue 5, 2007, Pages 579-586

  Grohmann, Ursula ^a   Volpi, Claudia ^a   Fallarino, Francesca ^a   Bozza, Silvia ^a   Bianchi, Roberta ^a   Vacca, Carmine ^a   Orabona, Ciriana ^a   Belladonna, Maria L ^a   Ayroldi, Emira ^a   Nocentini, Giuseppe ^a   Boon, Louis ^b   Bistoni, Francesco ^a   Fioretti, Maria C ^a   Romani, Luigina ^a   Riccardi, Carlo ^a   Puccetti, Paolo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b BIOCEROS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INDOLEAMINE 2,3 DIOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVATION; ENZYME INDUCTION; FEMALE; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; SIGNAL TRANSDUCTION; TRYPTOPHAN METABOLISM;

ANIMALS; DENDRITIC CELLS; DEXAMETHASONE; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; HUMANS; HYPERSENSITIVITY; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MICE; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; SPLEEN; TUMOR NECROSIS FACTORS;

EID: 34249725559     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1563     Document Type: Article

References (50)

1. van Essen, D., Kikutani, H. & Gray, D. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378, 620-623 (1995).
2. Eissner, G., Kolch, W. & Scheurich, P. Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system. Cytokine Growth Factor Rev. 15, 353-366 (2004).
3. Grohmann, U. et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3, 1097-1101 (2002).
4. Fallarino, F. et al. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4, 1206-1212 (2003).
5. Orabona, C. et al. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nat. Immunol. 5, 1134-1142 (2004).
6. Mellor, A.L. & Munn, D.H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4, 762-774 (2004).
7. Nocentini, G. & Riccardi, C. GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur. J. Immunol. 35, 1016-1022 (2005).
8. Shevach, E.M. & Stephens, G.L. The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nat. Rev. Immunol. 6, 613-618 (2006).
9. Nocentini, G. et al. A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc. Natl. Acad. Sci. USA 94, 6216-6221 (1997).
10. Tone, M. et al. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc. Natl. Acad. Sci. USA 100, 15059-15064 (2003).
11. Kim, J.D. et al. Cloning and characterization of GITR ligand. Genes Immun. 4, 564-569 (2003).
12. + regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3, 135-142 (2002).
13. + T cell activation and experimental autoimmune encephalomyelitis. J. Immunol. 172, 4686-4690 (2004).
14. + T cells. J. Immunol. 173, 5008-5020 (2004).
15. Ronchetti, S. et al. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur. J. Immunol. 34, 613-622 (2004).
16. + regulatory T cells. J. Exp. Med. 202, 885-891 (2005).
17. Seo, S.K. et al. 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat. Med. 10, 1088-1094 (2004).
18. Asselin-Paturel, C. et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2, 1144-1150 (2001).
19. Colonna, M., Trinchieri, G. & Liu, Y.J. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5, 1219-1226 (2004).
20. Ochando, J.C. et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol. 7, 652-662 (2006).
21. Mellor, A.L. et al. Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J. Immunol. 171, 1652-1655 (2003).
22. Fallarino, F. et al. Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J. Immunol. 173, 3748-3754 (2004).
23. Fallarino, F. & Puccetti, P. Toll-like receptor 9-mediated induction of the immunosuppressive pathway of tryptophan catabolism. Eur. J. Immunol. 36, 8-11 (2006).
24. Fallarino, F. et al. Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. Int. Immunol. 17, 1429-1438 (2005).
25. Muller, A.J., DuHadaway, J.B., Donover, P.S., Sutanto-Ward, E. & Prendergast, G.C. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat. Med. 11, 312-319 (2005).
26. Lawrence, T., Bebien, M., Liu, G.Y., Nizet, V. & Karin, M. IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation. Nature 434, 1138-1143 (2005).
27. Bonizzi, G. & Karin, M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280-288 (2004).
28. Kinoshita, D. et al. Essential role of IκB kinase α in thymic organogenesis required for the establishment of self-tolerance. J. Immunol. 176, 3995-4002 (2006).
29. - T cells to dexamethasone-induced cell death. Eur. J. Immunol. 34, 859-869 (2004).
30. Romani, L. Immunity to fungal infections. Nat. Rev. Immunol. 4, 1-23 (2004).
31. Judson, M.A. & Stevens, D.A. Current pharmacotherapy of allergic bronchopulmonary aspergillosis. Expert Opin. Pharmacother. 2, 1065-1071 (2001).
32. Montagnoli, C. et al. Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J. Immunol. 176, 1712-1723 (2006).
33. Romani, L. et al. Thymosin α1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. Blood 108, 2265-2274 (2006).
34. Romani, L. & Puccetti, P. Protective tolerance to fungi: the role of IL-10 and tryptophan catabolism. Trends Microbiol. 14, 183-189 (2006).
35. + regulatory T cells control autoimmunity? Curr. Opin. Immunol. 17, 638-642 (2005).
36. Grohmann, U., Fallarino, F. & Puccetti, P. Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol. 24, 242-248 (2003).
37. Orabona, C. et al. Towards the identification of a tolerogenic signature in IDO-competent dendritic cells. Blood 107, 2846-2854 (2006).
38. Gurtner, G.J., Newberry, R.D., Schloemann, S.R., McDonald, K.G. & Stenson, W.F. Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice. Gastroenterology 125, 1762-1773 (2003).
39. Hayashi, T. et al. Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J. Clin. Invest. 114, 270-279 (2004).
40. de Heer, H.J. et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 200, 89-98 (2004).
41. + dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN type 1 signaling. J. Immunol. 175, 5601-5605 (2005).
42. Wingender, G. et al. Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO. Eur. J. Immunol. 36, 12-20 (2006).
43. Yang, C.H., Murti, A. & Pfeffer, L.M. Interferon induces NF-κB-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-κB activation to promote cell survival. J. Biol. Chem. 280, 31530-31536 (2005).
44. Bonizzi, G. et al. Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers. EMBO J. 23, 4202-4210 (2004).
45. Gilliet, M. & Liu, Y.J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195, 695-704 (2002).
46. Ito, T. et al. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 204, 105-115 (2007).
47. Hwu, P. et al. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J. Immunol. 164, 3596-3599 (2000).
48. Fallarino, F. et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ζ-chain and induce a regulatory phenotype in naive T cells. J. Immunol. 176, 6752-6761 (2006).
49. Karagiannidis, C. et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J. Allergy Clin. Immunol. 114, 1425-1433 (2004).
50. Vacca, C. et al. CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig. Microbes Infect. 7, 1040-1048 (2005).